Literature DB >> 15362739

Primary and recurrent retroperitoneal sarcoma: factors affecting survival and long-term outcome.

Antonio Chiappa1, Andrew P Zbar, Roberto Biffi, Massimo Bellomi, Roberto Orecchia, Hugo Marsiglia, Emilio Bertani, Filippo De Braud, Cristiano Crotti, Bruno Andreoni.   

Abstract

BACKGROUND/AIMS: To analyze treatment and survival in a series of 39 patients with primary or recurrent retroperitoneal sarcoma treated and prospectively followed at a single institution.
METHODOLOGY: Between July 1994 and January 2002, 39 patients (20M, 19F; mean age: 56 years, range: 25-77) were evaluated.
RESULTS: Thirty-two out of 39 patients (82%) (18 were affected by primary retroperitoneal sarcoma, and 14 by recurrent retroperitoneal sarcoma), were submitted for resection. Twenty-four out of 32 patients (75%) underwent removal of contiguous intra-abdominal organs. Peroperative mortality was nil and significant peroperative complications occurred in 6 cases only (19%). High tumor grade results were a significant variable for a worse survival in all 32 patients (100% 5 years survival for low grade vs. 0% for high grade; P=0.0004). Among 27 radically resected patients, only histology gradeand peroperative blood transfusions affected survival (100% 5-year survival for low grade vs. 24% for high grade; P=0.003); (100% 5-year survival for nontransfused patients vs. 43% for transfused patients; P=0.03). Similar effects were noted for disease-free survival.
CONCLUSIONS: Histology grade and peroperative blood transfusions were the only factors which affected overall and disease-free survival. An aggressive surgical approach in both primary and recurrent retroperitoneal sarcoma is associated with long-term survival.

Entities:  

Mesh:

Year:  2004        PMID: 15362739

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Aggressive Surgical Approach for Treatment of Primary and Recurrent Retroperitoneal Soft Tissue Sarcoma.

Authors:  Antonio Chiappa; Emilio Bertani; Gabriella Pravettoni; Andrew Paul Zbar; Diego Foschi; Giuseppe Spinoglio; Bernardo Bonanni; Gianluca Polvani; Federico Ambrogi; Maria Laura Cossu; Carlo Ferrari; Marco Venturino; Cristiano Crosta; Luca Bocciolone; Roberto Biffi
Journal:  Indian J Surg       Date:  2018-01-31       Impact factor: 0.656

2.  Surgery combined with brachytherapy in patients with retroperitoneal sarcomas.

Authors:  Wirginiusz Dziewirski; Piotr Rutkowski; Zbigniew I Nowecki; Tadeusz Morysinski; Maciej Sałamacha; Anna Kulik; Maria Kawczynska; Anetta Kasprowicz; Jarosław Łyczek; Włodzimierz Ruka
Journal:  J Contemp Brachytherapy       Date:  2010-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.